Laurion Capital Management LP Iveric Bio, Inc. Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $20,443 - $26,893	-1,095 Reduced 2.11%	50,805 $1.24 Million
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $16,740 - $23,255	-971 Reduced 1.84%	51,900 $1.11 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $26,254 - $51,921	2,793 Added 5.58%	52,871 $949,000
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $3.11 Million - $6.44 Million	-340,615 Reduced 87.18%	50,078 $482,000
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $4.75 Million - $6.58 Million	390,693 New	390,693 $6.58 Million
Q1 2020 May 14, 2020	SELL	$2.83 - $8.44 $79,701 - $237,695	-28,163 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$0.93 - $8.58 $26,191 - $241,638	28,163 New	28,163 $242,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.